ArticleNature communications2022

Engineered bioorthogonal POLY-PROTAC nanoparticles for tumour-specific protein degradation and precise cancer therapy.

Jing Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.